VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARDT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARDTArdent Health Inc.
$17.75$2.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
ARDT logo

Ardent Health Inc.

ARDT
NYSE · Healthcare Providers
$17.75
At close - Nov 17, 4:00 PM EST - USD
Market Cap$2.54B
P/E17.2x
52W High$18.57
Volume455.15K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Thin Margins and Working Capital Swings Test ARDT Resilience

Ardent Health's revenue has plateaued near $1.6B per quarter, with year-over-year growth slowing to 2.7% in 2026Q3, suggesting top-line expansion has largely stalled after the 2025 peak.

GrowthMixed
ProfitabilityWeak
ValuationExpensive
TechnicalsStrong
Explore valuation models
MARKET ACTION

ARDT price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

7/12 Beats

EPS beat 7 of last 12 quarters

02

Valuation risk

-18% Peers

P/E is 18% below peer median

03

Market leadership

RS 97 · Leader

High momentum (Outperforming 97% of market)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Feb 4

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
ARDT+105.44%
S&P 500 (^GSPC)+7.21%
1-Year Return
ARDT+114.37%
S&P 500 (^GSPC)+10.03%
3-Year Return
ARDT+10.52%
S&P 500 (^GSPC)+59.70%
5-Year Return
ARDT+10.52%
S&P 500 (^GSPC)+53.62%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
17.2x
Forward P/E
18.8x
EV/EBITDA100th %ile
8.4x
FCF YieldCash Flow
11.0%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
17.2x
10.8x
100th· High
EV/EBITDA
8.4x
7.2x
100th· High
Price/FCF
9.1x
17.8x
50th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$7.89-55.5%
Base (Fair)$21.27+19.5%
Bull$42.11+137.2%
$7.89 Bear$21.27 Base$42.11 Bull
Current Market Price: $17.75
Trades at a 16.5% discount to Base DCF ($21.27)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$6.32B+6.0% YoY
Net income FY25
$136M-35.4% YoY
Free cash flow FY25
$259M+102.8% YoY
Operating margin FY25
5.1%-1.7 pts YoY
ROIC (FY25)7.5%
Avg ROIC 5Y7.2%
ROE (TTM)8.4%
Piotroski Score6 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate7/12 (70%)
Revenue Beat Rate7/12 (70%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 4, 2026
$0.31+33.6%
vs $0.23
$1.6B+1.3%
vs $1.6B
Q3 2026
Aug 4, 2026
$0.12-34.0%
vs $0.18
$1.6B+2.0%
vs $1.6B
Q2 2026
May 5, 2026
$0.28+55.6%
vs $0.18
$1.6B+1.5%
vs $1.6B
Q2 2026
Mar 4, 2026
$0.32-8.0%
vs $0.35
$1.6B-1.6%
vs $1.6B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
MarketBeat·Nov 6, 2026
What Ardent Health (ARDT) Said on Its Q3 Earnings Call

Ardent Health NYSE: ARDT raised the lower end of its full-year adjusted EBITDA forecast after reporting $1.62 billion in third-quarter revenue and $138 million in adjusted EBITDA, as lower labor costs and improving patient volumes supported results.

Seeking Alpha·Nov 5, 2026
Ardent Health, Inc. (ARDT) Q3 2026 Earnings Call Transcript

Ardent Health, Inc. ( ARDT ) Q3 2026 Earnings Call November 5, 2026 10:00 AM EST Company Participants David Styblo - Senior Vice President of Investor Relations David Caspers - President, CEO & Director Alfred Lumsdaine - Chief Financial Officer Conference Call Participants Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Craig Hettenbach - Morgan Stanley, Research Division Kevin Fischbeck - BofA Securities, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Sean Dodge - BMO Capital Markets Equity Research Sarah Conrad - Goldman Sachs Group, Inc., Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us and welcome to the Ardent Health Third Quarter 2026 Earnings Conference Call. [Operator Instructions] I'll now hand the conference over to Dave Styblo, Lead Investor Relations.

Zacks Investment Research·Nov 4, 2026
Ardent Health, Inc. (ARDT) Beats Q3 Earnings and Revenue Estimates

Ardent Health, Inc. (ARDT) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.52 per share a year ago.

Business Wire·Nov 4, 2026
Ardent Health Reports Third Quarter 2026 Results

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2026. Third Quarter 2026 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key.

Filtered for Ardent Health Inc.More Headlines
04

Compare before deciding

Benchmark ARDT against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Ardent Health Inc. (ARDT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ARDT logoARDTArdent Health Inc.Current
$17.75$2.54B17.206.01%2.27%8.42%—
HCA logoHCAHCA Healthcare, Inc.
$501.19$108.51B16.077.08%8.61%—0.59%
THC logoTHCTenet Healthcare Corporation
$282.07$24.3B7.843.12%12.71%32.11%—
CYH logoCYHCommunity Health Systems, Inc.
$2.02$284.84M-0.53-1.18%-2.34%——
UHS logoUHSUniversal Health Services, Inc.
$191.98$11.62B7.779.71%7.96%19.27%0.41%
ENSG logoENSGThe Ensign Group, Inc.
$186.02$10.84B27.6418.72%7.03%16.61%0.13%

Compare ARDT vs Peers

Ardent Health Inc. (ARDT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCA

Most directly comparable listed peer for ARDT.

Scale Benchmark

vs UNH

Larger-name benchmark to compare ARDT against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCA, THC, CYH, UHS

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

ARDT SEC Filings & Documents

Ardent Health Inc. (ARDT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 4, 2026·SEC

Material company update

Oct 23, 2026·SEC

Material company update

Aug 4, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 16, 2026·SEC

FY 2025

Feb 27, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 5, 2026·SEC

FY 2026

Aug 10, 2026·SEC

FY 2026

May 6, 2026·SEC

Get notified when ARDT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ARDT Frequently Asked Questions

Ardent Health Inc. (ARDT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Ardent Health Inc.'s revenue?

Ardent Health Inc. (ARDT) reported $6.45B in revenue over the trailing twelve months. Revenue was $6.32B in fiscal year 2025. That is 200% more than the $2.11B of fiscal year 2016.

How fast is Ardent Health Inc. growing?

Ardent Health Inc. (ARDT) grew revenue by 2.0% over the trailing twelve months, compared with the twelve months before.

Is ARDT profitable?

Yes. Ardent Health Inc. (ARDT) earned $146.2M in net income over the trailing twelve months (a 2.3% net margin).

Dividend & Returns
What is ARDT's return on equity?

Ardent Health Inc. (ARDT) had a return on equity (ROE) of 8.4% over the trailing twelve months. That is below the market's typical 10-15%.

What is Ardent Health Inc.'s free cash flow?

Ardent Health Inc. (ARDT) generated $280.7M in free cash flow over the trailing twelve months.

What if you invested $1,000 in ARDT back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →